Profits from music back catalogues dry up for Hipgnosis
Making money from buying up music back catalogues looked attractive when interest rates were low. Now, not so much.
Under the swashbuckling leadership of its founder Merck Mercuriadis, Hipgnosis was one of the dazzling successes of the London stockmarket over the last decade, and proof, if you wished to look at it that way, that for all its current problems, the City was still good at financial innovation.
A hugely successful former music industry executive, Mercuriadis teamed up with songwriter and performer Nile Rodgers – one of the leaders of Chic, and a collaborator with David Bowie and Madonna – to raise a fund that would acquire the rights to song catalogues.
With an initial £300m, over the next few years, Hipgnosis raised more than £1bn from investors and used the money to buy the catalogues of Fleetwood Mac stars Mick Fleetwood and Christine McVie, Blondie, 10cc, the Red Hot Chilli Peppers and many more. Along the way, it created a whole new asset class, with several rival music funds competing with each other to snap up the most valuable catalogues. Bruce Springsteen seems to have called the top of the market when he sold his songs to Sony for a reported $500m. It seems they don’t call him “The Boss” for nothing.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
True, there was always an intriguing case to be made for the idea. Especially with the development of streaming, back catalogues of songs were more valuable than ever. Consumers on Spotify and Apple Music could dip in and out of decades of music far more easily than they ever could when it was only available on vinyl or CDs, and each time a song was played it generated a little bit of money. Catalogues that generated only a few CD sales a year, or that may even have disappeared completely, were worth something online. Even better, Hipgnosis argued that its marketing savvy could significantly increase the value of each track, either by generating more streams or by licensing it out for use in films, TV or video games.
The catalogues might have cost a lot to acquire, just like any asset, but once they were inside the portfolio they could generate a steady and rising income. That was always going to be worth something to investors.
So, why is Hipgnosis in trouble?
And yet right now Hipgnosis is imploding. A plan to sell a big chunk of its catalogue to Blackstone was blocked by shareholders. Its founder has now launched legal action against the fund. It is searching for new auditors after PwC refused to reapply for the role, a development that hardly inspires confidence in the state of its accounts. There are questions about the way that Hipgnosis royalties are calculated. The shares are down by 21% so far this year as investors steadily lose confidence in the entire market.
True, there are always individual businesses within any sector that run into trouble, and Hipgnosis may well be able to get itself back on track over the next year. And yet the very survival of the asset class is now open to question.
There were two big problems with the song funds. First, they relied on very low interest rates. When rates were at 0.5%, or even lower, as they were for most of the last decade, investors were desperate for income. Generating 5% or 6% on a collection of old songs looked pretty good. Now that you can get 5% just by parking your money in the bank, or buying government bonds, it looks a lot less attractive. Second, the funds depended critically on the idea that revenues would keep on growing. That turned out not to be the case. The music streaming market is now more or less saturated, and the likes of Spotify are finding it very hard to force through price rises, even with high rates of inflation. And there are only so many TV shows that want the rights to old Fleetwood Mac songs.
In a bull market, financial engineers are always looking for clever new ways to make money. In the 1980s and 1990s, it was junk bonds. In the 2000s it was subprime mortgages. We may well have seen it in the 2010s with the idea that old music catalogues were an asset that could be traded and monetised on an industrial scale.
There are never really any new ways of making lots of easy money. It always blows up eventually – it is just a question of when.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Related articles
- Merck Mercuriadis: the mogul shaking up the music business
- Music royalties fund Hipgnosis strikes a discordant note
- Artists demand a fair share of the music industry pie
- Grab a piece of art – or music – with fractional ownership
- How Taylor Swift is boosting the economy
Matthew Lynn is a columnist for Bloomberg, and writes weekly commentary syndicated in papers such as the Daily Telegraph, Die Welt, the Sydney Morning Herald, the South China Morning Post and the Miami Herald. He is also an associate editor of Spectator Business, and a regular contributor to The Spectator. Before that, he worked for the business section of the Sunday Times for ten years.
He has written books on finance and financial topics, including Bust: Greece, The Euro and The Sovereign Debt Crisis and The Long Depression: The Slump of 2008 to 2031. Matthew is also the author of the Death Force series of military thrillers and the founder of Lume Books, an independent publisher.
-
Should you sell in May this year?
The market adage looks unlikely to apply in 2024, and global equities are proving resilient
By Max King Published
-
Should you invest in UK equities?
The FTSE 100 hit a record high this week, but UK equities remain unloved and undervalued compared to their global and US peers. Should you snap them up at a discount?
By Katie Williams Published
-
AstraZeneca CEO’s £1.8mn pay rise approved despite shareholder opposition
AstraZeneca hiked its dividend to persuade shareholders to accept CEO Pascal Soriot’s pay rise. Is he worth his salary?
By Dr Matthew Partridge Published
-
Adidas, Nike or Jordans - could collectable trainers make you rich?
The right pair of trainers can fetch six figures. Here's how you can start collecting vintage Adidas, Nike or Jordans now
By Chris Carter Published
-
The industry at the heart of global technology
The semiconductor industry powers key trends such as artificial intelligence, says Rupert Hargreaves
By Rupert Hargreaves Published
-
Three emerging Asian markets to invest in
Professional investor Chetan Sehgal of Templeton Emerging Markets Investment Trust tells us where he’d put his money
By Chetan Sehgal Published
-
What to consider before investing in small-cap indexes
Small-cap index trackers show why your choice of benchmark can make a large difference to long-term returns
By Cris Sholto Heaton Published
-
Why space investments are the way to go for investors
Space investments will change our world beyond recognition, UK investors should take note
By Merryn Somerset Webb Published
-
Time to tap into Africa’s mobile money boom
Favourable demographics have put Africa on the path to growth when it comes to mobile money and digital banking
By Rupert Hargreaves Published
-
M&S is back in fashion: but how long can this success last?
M&S has exceeded expectations in the past few years, but can it keep up the momentum?
By Rupert Hargreaves Published